European Urology Focus

Slides:



Advertisements
Similar presentations
Diana Cardona-Grau, Igor Sorokin, Gabriel Leinwand, Charles Welliver 
Advertisements

European Urology Focus
Maria Carmen Mir, Cesar Ercole, Andrew Stephenson
Volume 51, Issue 2, Pages (February 2007)
European Urology Focus
Volume 66, Issue 6, Pages (December 2014)
Global Trends in Testicular Cancer Incidence and Mortality
Volume 52, Issue 5, Pages (November 2007)
The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks  Marcus G.
Volume 60, Issue 2, Pages (August 2011)
European Urology Oncology
Volume 66, Issue 1, Pages (July 2014)
Volume 61, Issue 5, Pages (May 2012)
Volume 63, Issue 4, Pages (April 2013)
Volume 53, Issue 5, Pages (May 2008)
Volume 69, Issue 1, Pages (January 2016)
Volume 63, Issue 3, Pages e39-e40 (March 2013)
Volume 72, Issue 5, Pages (November 2017)
Volume 51, Issue 5, Pages (May 2007)
Prostate Cancer Epidemic in Sight?
Volume 52, Issue 4, Pages (October 2007)
Volume 61, Issue 4, Pages (April 2012)
Volume 63, Issue 4, Pages (April 2013)
Volume 63, Issue 1, Pages (January 2013)
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 68, Issue 5, Pages (November 2015)
Volume 61, Issue 5, Pages (May 2012)
What is New in Hormone Therapy for Prostate Cancer in 2007?
Volume 61, Issue 4, Pages (April 2012)
Volume 73, Issue 3, Pages (March 2018)
Volume 71, Issue 5, Pages (May 2017)
Volume 69, Issue 3, Pages (March 2016)
Volume 57, Issue 4, Pages e41-e42 (April 2010)
Prostate Cancer Epidemic in Sight?
Volume 71, Issue 6, Pages (June 2017)
Stephen B. Williams, Ashish M
Global Burden of Urologic Cancers, 1990–2013
Volume 66, Issue 6, Pages (December 2014)
Volume 66, Issue 6, Pages (December 2014)
Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward?  Michel Bolla  European.
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study  Stephen H. Culp, Paul.
Volume 53, Issue 1, Pages (January 2008)
Volume 68, Issue 4, Pages (October 2015)
Volume 69, Issue 6, Pages (June 2016)
Volume 55, Issue 6, Pages (June 2009)
Cost-Effectiveness Analysis of a Screening Program for Breast Cancer in Vietnam  Lan Hoang Nguyen, Wongsa Laohasiriwong, John Frederick Stewart, Pamela.
Volume 71, Issue 5, Pages (May 2017)
Volume 53, Issue 1, Pages (January 2008)
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy  Matthew Mossanen, Kenneth.
Volume 74, Issue 4, Pages (October 2018)
European Urology Oncology
Volume 59, Issue 4, Pages (April 2011)
Prognostic Impact of Comorbidity in Patients with Bladder Cancer
Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study  J.-Y. Feng, S.-F. Huang, W.-Y. Ting, Y.-C.
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
European Urology Oncology
Georges-Pascal Haber, Sebastien Crouzet, Inderbir S. Gill 
Manfred Wirth, Peter Iversen, David McLeod, William See 
Fernando P. Secin, Fernando J. Bianco, Nicholas T
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Adherence to endovascular aortic aneurysm repair device instructions for use guidelines has no impact on outcomes  Joy Walker, MD, Lue-Yen Tucker, BA,
Volume 51, Issue 2, Pages (February 2007)
Volume 52, Issue 1, Pages (July 2007)
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Maximilian Burger, Ashish M. Kamat, David McConkey 
Presentation transcript:

European Urology Focus Selection Effects May Explain Smoking-related Outcome Differences After Radical Cystectomy  Michael Froehner, Rainer Koch, Matthias Hübler, Ulrike Heberling, Vladimir Novotny, Stefan Zastrow, Gustavo B. Baretton, Manfred P. Wirth  European Urology Focus  DOI: 10.1016/j.euf.2016.10.003 Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 1 Cumulative mortality curves for overall mortality (deaths from all causes), bladder cancer–specific mortality (deaths due to uncontrolled bladder cancer progression), and competing mortality (deaths in the absence of uncontrolled bladder cancer progression) stratified by smoking status. Univariate analyses revealed no detectable differences among current smokers, former smokers, and nonsmokers (log-rank test and Pepe-Mori test, p values ranging between 0.1804 and 0.7678). European Urology Focus DOI: (10.1016/j.euf.2016.10.003) Copyright © 2016 European Association of Urology Terms and Conditions